IP Library Patent Application 11492293
Patent Application
App. No. 11/492,293

Neutralizing factors as vaccine adjuvants

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/492,293
Abstract

The present invention is a vaccine adjuvant composed of a vaccinia virus vector that encodes a polypeptides capable of neutralizing immune suppressive factors thereby enhancing or stimulating an immune response to a vaccine.

Claims (4)

1 . A vaccine adjuvant comprising a vaccinia virus vector encoding at least one polypeptide that neutralizes an immune suppressive factor.

2 . A method for enhancing an immune response to a vaccine comprising administering a vaccine in combination with the vaccine adjuvant of claim 1 to a subject so that the cells of the subject express the at least one polypeptide thereby enhancing an immune response to the vaccine in the subject.

3 . The method of claim 3 , further comprising administering a second vaccinia virus vector encoding an immune active cytokine.

4 . A kit comprising a formulated vaccine adjuvant of claim 1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2006
From: LATTIME, EDMUND C.; MONKEN, CLAUDE
To: NEW JERSEY, UNUIVERSITY OF MEDICINE AND DENTISTRY OF
Reel/Frame 018575/0164 →